Scheduled Drugs in Pain Management
Scheduled drugs should be used in pain management according to the WHO analgesic ladder, with appropriate titration, monitoring, and safeguards to minimize risks while maximizing pain control and quality of life. 1
Principles of Pain Management with Scheduled Drugs
Assessment and Medication Selection
- Pain intensity should be regularly assessed using validated tools such as visual analog scales (VAS), verbal rating scales (VRS), or numerical rating scales (NRS) 1
- Select analgesics based on pain severity following the WHO analgesic ladder 1:
- Mild pain: Non-opioid analgesics (paracetamol/acetaminophen, NSAIDs)
- Moderate pain: Weak opioids (codeine, tramadol) plus non-opioids
- Severe pain: Strong opioids (morphine, oxycodone) plus non-opioids
Opioid Administration Guidelines
- Regular scheduling: Prescribe analgesics for chronic pain on a regular basis, not "as needed" 1
- Route preference: Oral administration should be the first choice when possible 1
- Breakthrough pain coverage: Always prescribe rescue doses for breakthrough pain episodes 1, 2
- Titration process:
Special Considerations
Renal Impairment
- Use all opioids with caution at reduced doses and frequency in renal impairment 1
- Fentanyl and buprenorphine (transdermal or IV) are safest for patients with chronic kidney disease stages 4-5 1
Side Effect Management
- Constipation: Routinely prescribe laxatives for both prophylaxis and management 1
- Nausea/vomiting: Use metoclopramide or antidopaminergic drugs 1
- Sedation: Monitor for excessive sedation, especially when combining multiple CNS depressants 2
Patient Education and Monitoring
Essential Patient Education Points
- Inform patients that pain relief is medically important and suffering is not beneficial 1
- Explain that when used appropriately for pain, addiction is rarely a problem 1
- Emphasize that scheduled drugs must be properly safeguarded and not mixed with alcohol or illicit substances 1
Documentation Requirements
Provide patients with written information including 1:
- Complete medication list with instructions
- Potential side effects and management strategies
- Clear instructions on when to contact healthcare providers
- Follow-up plan
Safety Precautions
Risk Mitigation
- Use the lowest effective dosage for the shortest duration consistent with treatment goals 3
- Monitor patients closely for respiratory depression, especially within the first 24-72 hours 3
- Consider opioid switching if pain relief is inadequate or side effects are problematic 1
High-Risk Patients
- For patients with history of substance abuse, implement additional monitoring and structure 4
- In elderly patients or those with comorbidities, start with lower doses and titrate more slowly 1
Multimodal Approaches
Non-Pharmacologic Interventions
- Incorporate cognitive-behavioral techniques, relaxation strategies, and physical modalities 5
- For cancer-related bone pain, consider radiation therapy for painful bone metastases 1
- For neuropathic pain components, add adjuvant medications (anticonvulsants, antidepressants) 1
Common Pitfalls to Avoid
- Underdosing: Inadequate pain control leads to decreased function and quality of life 4
- Overreliance on PRN dosing: For chronic pain, scheduled dosing provides better control 1
- Ignoring breakthrough pain: Always provide rescue medication for breakthrough episodes 1, 2
- Neglecting side effect management: Proactively address constipation, nausea, and sedation 1
- Poor documentation: Maintain detailed records of assessments, treatment plans, and medication changes 6
By following these evidence-based guidelines, clinicians can effectively use scheduled drugs to manage pain while minimizing risks and optimizing patient outcomes.